PE Ratio
20.86
₹160.50 0.20 (0.12%)
As on September 4, 2026
-46.14%
1 Y CAGR
177
CR
Market Cap
Company profile
Vaidya Sane Ayurved Laboratories Ltd., operating commercially as Madhavbaug, is an Indian specialist healthcare provider focused on the non-invasive treatment and management of lifestyle-related chronic diseases, primarily cardiac ailments, diabetes, hypertension, obesity, and knee pain. The company integrates traditional Ayurvedic practices with modern medical diagnostics. It operates a network of multidisciplinary clinics and two cardiac hospitals across various Indian states, offering clinical consultations, specialized Ayurvedic procedures, and chronic disease reversal programs. Additionally, the company is involved in the research, development, and sale of proprietary Ayurvedic medicines, health supplements, and wellness products, which are distributed through its clinics, e-pharmacy platform, and online portals. Its target market includes individuals in India suffering from these chronic conditions, leveraging an integrated approach within the chronic care ecosystem.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.24
Dividend Yield
0.17%
Sector PE
47.63
Sector ROE
11.70%
Sector Dividend Yield
0.46%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹1.1KCAGR 5-Year
+9.37%Peers & Comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
DIVISLAB
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
TORNTPHARM
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
